Pneumonic plague is the deadliest form of disease caused by Yersinia pestis and the basis for this bacterium's classification as a Category A Select Agent. Most studies of plague pathogenesis have focused on the bubonic route of infection, and most research on the pathogen has been performed with attenuated, avirulent or related species of Yersinia. A more complete picture of pneumonic plague has emerged from the development of a mouse model of infection showing that pulmonary disease caused by fully virulent Y. pestis progresses in two distinct stages: an extended pre-inflammatory phase followed by a robust pro-inflammatory phase that leads to severe bronchopneumonia and mortality. The ultimate goal of this proposal is to obtain a more complete understanding of respiratory immune cell interactions, activation and depletion by Y. pestis during the pre-inflammatory phase of pneumonic plague. We will use both bacterial and host mutants to further characterize the effects of these early bacterial - host cell interactions on pathogenesis.
Specific Aim 1. Characterize early interactions between Y. pestis and host cells in the lung. Our hypothesis is that Y. pestis targets specific immune cell populations in the lung to achieve directed and localized suppression of innate immunity. The studies in this Aim will characterize the lung cells targeted by the type III secretion system in vivo and evaluate host cell population changes that occur during the preinflammatory phase.
Specific Aim 2. Characterize Y. pestis-mediated inflammasome activation and its contribution to disease progression/pathology. Preliminary data demonstrates that fully virulent Y. pestis activates the inflammasome soon after inoculation both in vitro and in vivo. This is striking, as no signs of inflammation or pathology are visible at this early stage of infection. The studies in this Aim are designed to identify both the bacterial and host contributor to this response, as well as evaluate the importance of this early cytokine activation to later immunopathogenesis.

Public Health Relevance

The highly pathogenic bacterium Yersinia pestis is the causative agent of pneumonic plague, the most severe and lethal form of plague. In recent years, there is significant concern that Y. pestis may be used as a bioterrorism agent due to its ease of aerosol dissemination and the short time course of pulmonary disease. If antibiotics are not administered within a very narrow window of time following the emergence of respiratory symptoms, death is unavoidable. A thorough understanding of both bacterial and immunological determinants of disease must be developed so that prophylactics and better therapeutics can be developed.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IDM-A (80))
Program Officer
Mukhopadhyay, Suman
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Schools of Medicine
Chapel Hill
United States
Zip Code
Sivaraman, Vijay; Pechous, Roger D; Stasulli, Nikolas M et al. (2015) Yersinia pestis activates both IL-1? and IL-1 receptor antagonist to modulate lung inflammation during pneumonic plague. PLoS Pathog 11:e1004688
Stasulli, Nikolas M; Eichelberger, Kara R; Price, Paul A et al. (2015) Spatially distinct neutrophil responses within the inflammatory lesions of pneumonic plague. MBio 6:e01530-15
Pechous, Roger D; Broberg, Christopher A; Stasulli, Nikolas M et al. (2015) In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation. MBio 6:e02302-14
Pechous, Roger D; Sivaraman, Vijay; Price, Paul A et al. (2013) Early host cell targets of Yersinia pestis during primary pneumonic plague. PLoS Pathog 9:e1003679